Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Familial Cancer
Published in: Familial Cancer 2/2005

01-06-2005

Genetic uptake in BRCA-mutation families is related to emotional and behavioral communication characteristics of index patients

Authors: Karin Landsbergen, Chris Verhaak, Floor Kraaimaat, Nicoline Hoogerbrugge

Published in: Familial Cancer | Issue 2/2005

Login to get access
Metadata
Title
Genetic uptake in BRCA-mutation families is related to emotional and behavioral communication characteristics of index patients
Authors
Karin Landsbergen
Chris Verhaak
Floor Kraaimaat
Nicoline Hoogerbrugge
Publication date
01-06-2005
Publisher
Kluwer Academic Publishers
Published in
Familial Cancer / Issue 2/2005
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-004-7991-2

Other articles of this Issue 2/2005

Familial Cancer 2/2005 Go to the issue

OriginalPaper

SISE matters: the Sum of Information on Seventy-yr-old Equivalents measures pedigree information content when assessing the risk of HNPCC in a family

OriginalPaper

The use of preventive measures among healthy women who carry a BRCA1 or BRCA2 mutation

OriginalPaper

The Tyr978X BRCA1 mutation: occurrence in non-Jewish Iranians and haplotype in French-Canadian and non-Ashkenazi Jews

OriginalPaper

The CHEK2 1100delC allele is not relevant for risk assessment in HNPCC and HBCC Spanish families

OriginalPaper

Informing one’s family about genetic testing for hereditary non-polyposis colorectal cancer (HNPCC): a retrospective exploratory study

OriginalPaper

An unusual case of Turcot’s syndrome associated with ileal adenocarcinoma, intestinal non-Hodgkin’s lymphoma, and duodenal adenocarcinoma. Review of the classification and genetic basis of Turcot’s syndrome
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits